Purslane suppresses osteoclast differentiation and bone resorbing activity via inhibition of Akt/GSK3β-c-Fos-NFATc1 signaling in vitro and prevents lipopolysaccharide-induced bone loss in vivo
Cited 35 time in 
Metadata Downloads
- Title
- Purslane suppresses osteoclast differentiation and bone resorbing activity via inhibition of Akt/GSK3β-c-Fos-NFATc1 signaling in vitro and prevents lipopolysaccharide-induced bone loss in vivo
- Author(s)
- J Y Kim; Hyun-Mee Oh; S C Kwak; Y H Cheon; M S Lee; Mun Chual Rho; J Oh
- Bibliographic Citation
- Biological & Pharmaceutical Bulletin, vol. 38, no. 1, pp. 66-74
- Publication Year
- 2015
- Abstract
- Akt/GSK3β-c-Fos-NFATc1 signaling cascades. Therefore, purslane is a potential natural medicine for the treatment of osteoclast-related diseases.
- ISSN
- 0918-6158
- Publisher
- Pharmaceutical Soc Japan
- Full Text Link
- http://dx.doi.org/10.1248/bpb.b14-00567
- Type
- Article
- Appears in Collections:
- Jeonbuk Branch Institute > Functional Biomaterial Research Center > 1. Journal Articles
- Files in This Item:
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.